Watch now! Oved Amitay talks to Llewellyn King on “ME/CFS Alert”

In the most recent episode of “ME/CFS Alert,” host Llewellyn King interviewed Solve M.E. President and CEO, Oved Amitay. Oved, a registered pharmacist and public health expert who has dedicated his professional career to the development of therapeutic options for people affected by rare genetic diseases, spoke to King about the recent $1.15 billion congressional […]

Read More

Solve M.E. Partners with UCLA on ME/CFS Research on Brain Stimulation

We’re excited to announce that Solve M.E. has partnered with the University of California, Los Angeles (UCLA) Iris Cantor Women’s Health Center to expand ME/CFS research through their Annual Health Pilot Program—the first time an ME/CFS study has been included. Solve M.E. will support a study by the UCLA Neuromodulation Division on a promising investigational treatment. The partnership is generously […]

Read More

Why Long-COVID?

The Long COVID Alliance is a coalition of different complex, chronic, disease organizations who have come together to pool our resources. Each group is bringing along their expertise as well as their connections with patient advocates, disease experts, drug developers, and more. The top three symptoms of long-COVID are the top three symptoms of ME/CFS, […]

Read More

Ramsay Grant Program 2021 RFA is Open!

Solve M.E. will accept applications to study ME/CFS and Long-Covid from February 22 – April 30, 2021 Through the Ramsay Program, Solve M.E. invests in research studies in ME/CFS or long-COVID with a particular emphasis on engaging young investigators and researchers new to the field. Collaborative proposals (involving 2 or more research groups) and studies […]

Read More

NIH launches database to track neurological symptoms associated with COVID-19

A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. The COVID-19 Neuro Databank/Biobank (NeuroCOVID), which was created and will be maintained by NYU Langone Health, New York City, will be a resource of clinical information as well as biospecimens from […]

Read More

2019 Congressional Champions of ME/CFS

The following is a list of our Congressional Champions who supported ME Research and Funding. In order to increase funding for ME/CFS research and education, we had TWO appropriations request letters: DEFENSE & LABOR-HHS. Labor-HHS Appropriations: Preserved $5.4 million for 2020 to fund the Multi-site Clinical Assessment of ME/CFS (which recently expanded into pediatric study) and […]

Read More

Solve ME/CFS Initiative Calls for Review of PACE Trial

The Solve ME/CFS Initiative is one of 12 organizations that have signed a letter asking the heads of the Centers for Disease Control (CDC) and the Agency for Healthcare Research and Quality (AHRQ) to examine the issues raised by journalist David Tuller’s analysis of the U.K.’s £5 million PACE trial for ME/CFS. Read More…

Read More

Peter Rowe – Part Two

In Part Two of his follow-up to our July 16 webinar, Dr. Peter Rowe, director of the Chronic Fatigue Clinic at Johns Hopkins Children’s Center, responds to patients’ questions on orthostatic intolerance, methylation, beta blockers and the effects of talking during tilt table testing. Read More…

Read More